News
Archive
Archive
NATURE: “Norway to bring cancer-gene tests to the clinic”
NATURE: “Norway to bring cancer-gene tests to the clinic”
February 02, 2012
An article about Norway's program for stratified cancer treatment was published in the prestige science journal Nature on February 2nd 2012. It was stated that: “Norway is set to become the first... » Read more...

New prognostic test for improved cancer treatment
New prognostic test for improved cancer treatment
January 31, 2012
Researchers at the Oslo University Hospital have developed a gene signature that is suitable to be developed into a prognostic test for patients with stage II colorectal cancer. The test has bee... » Read more...

Tone Yrvum has resigned from her position
Tone Yrvum has resigned from her position
January 30, 2012
Tone Yrvum has announced that she resign her position as Chief Executive Officer of Oslo Cancer Cluster to explore new challenges.  

Targovax secures funding for cancer vaccine
Targovax secures funding for cancer vaccine
January 27, 2012
Targovax has secured almost 13 MNOK (2.2 MUSD) from the Radium Hospital Research Foundation, Birk Venture, RO Invest and existing owners for further development of a cancer vaccine against pancreas ca... » Read more...

Nordic Nanovector Raises 14.3 MNOK
Nordic Nanovector Raises 14.3 MNOK
January 25, 2012
Oslo Cancer Cluster member Nordic Nanovector recently announced that the company has raised 14.3 million NOK in gross proceeds through a private placement. The company are developing innovat... » Read more...

Personalized Cancer Care Symposium
Personalized Cancer Care Symposium
January 25, 2012
Top researchers from US, Europe and Asia will meet in Oslo September 7 - 9 2012 to discuss the latest development in the field of personalized cancer care. The focus of the meeting will... » Read more...

Kick-off for targeted cancer program
Kick-off for targeted cancer program
January 24, 2012
The research group Norwegian Cancer Genomics Consortium (NCGC) has sought funding for a three-year research project to study genetic changes in cancer tumors. Oslo Cancer Cluster is supporting this in... » Read more...

BerGenBio raises $9 million
BerGenBio raises $9 million
January 10, 2012
BerGenBio AS, an emerging oncology biopharma company, today announced it has completed an $8.8 million Series A financing round. The financing will be used primarily to take lead compound BGB324 into ... » Read more...

"Bioteknologi for Dummies"
"Bioteknologi for Dummies"
January 03, 2012
Jobber du med bioteknologi, men mangler kunnskap om biologi? Eller har du lyst til å lære mer om et spennende og viktig fagfelt i utvikling? I begge tilfeller er Forskerfabrikkens kurs i bioteknologi ... » Read more...

Cancer Crosslinks 2012
Cancer Crosslinks 2012
December 30, 2011
The annual Cancer Crosslinks seminar is closing in: January 12th 2012 the Auditorium at the New Research Building at The Radium Hospital will be filled with oncologists, hematologists and clinicians f... » Read more...

Latest eventsFacebookTwitterBlogVideo
Monday, February 06, 2012 2:00 PM
Tuesday, February 07, 2012 8:00 AM
Monday, February 13, 2012 12:00 AM
Wednesday, February 15, 2012 11:00 AM
Oslo Cancer Cluster · Vollsveien 6, 1366 Lysaker · +47 971 09 585 · Fax: +47 67 12 26 58 · E-mail: mbl@radforsk.no
Utviklet av React Solutions og designet av Rim Ide & kommunikasjon